Effect of milk tripeptides on blood pressure: A meta-analysis of randomized controlled trials

Nutrition

Volumn 24, Issue 10, 2008, Pages 933-940

  Xu, Jia Ying ^a   Qin, Li Qiang ^a   Wang, Pei Yu ^b   Li, Wei ^a   Chang, Chun ^b  

^a SOOCHOW UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Blood pressure; Hypertension; Meta analysis; Milk; Tripeptide

Indexed keywords

ISOLEUCYLPROLYLPROLINE; MILK PROTEIN; TRIPEPTIDE; UNCLASSIFIED DRUG; VALYLPROLYLPROLINE;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; FOOD INTAKE; HUMAN; HYPERTENSION; HYPOTENSION; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE;

AGED; BLOOD PRESSURE; DIASTOLE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MILK PROTEINS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SYSTOLE; TIME FACTORS; TREATMENT OUTCOME;

EID: 50549086234     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2008.04.004     Document Type: Article

References (43)

1. Stamler R. Implications of the INTERSALT study. Hypertension 17 suppl I (1991) 16-20
2. Collins R., Peto R., MacMahon S., Hebert P., Fiebach N.H., Eberlein K.A., et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 335 (1990) 827-838
3. Asayama K., Ohkubo T., Kikuya M., Metoki H., Hoshi H., Hashimoto J., et al. Prediction of stroke by self-measurement of blood pressure at home versus casual screening blood pressure measurement in relation to the Joint National Committee 7 classification: the Ohasama study. Stroke 35 (2004) 2356-2361
4. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
5. World Health Organization. The world health report 2002: reducing risks to health, promoting healthy life (2002), World Health Organization, Geneva
6. Wang Y., and Wang Q.J. The prevalence of prehypertension and hypertension among US adults according to the New Joint National Committee Guidelines. Arch Intern Med 164 (2004) 2126-2134
7. Sun Z., Zheng L., Wei Y., Li J., Zhang X., Zhang X., et al. The prevalence of prehypertension and hypertension among rural adults in Liaoning province of China. Clin Cardiol 30 (2007) 183-187
8. Appel L.J., Brands M.W., Daniels S.R., Karanja N., Elmer P.J., and Sacks F.M. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 47 (2006) 296-308
9. Appel L.J., Moore T.J., Obarzanek E., Vollmer W.M., Svetkey L.P., Sacks F.M., et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 336 (1997) 1117-1124
10. Xin X., He J., Frontini M.G., Ogden L.G., Motsamai O.I., and Whelton P.K. Effects of alcohol reduction on blood pressure. A meta-analysis of randomized controlled trials. Hypertension 38 (2001) 1112-1117
11. Neter J.E., Stam B.E., Kok F.J., Grobbee D.E., and Geleijnse J.M. Influence of weight reduction on blood pressure. A meta-analysis of randomized controlled trials. Hypertension 42 (2003) 878-884
12. Alonso A., Beunza J.J., Delgado-Rodríguez M., Martínez J.A., and Martínez-González M.A. Low-fat dairy consumption and reduced risk of hypertension: the Seguimiento Universidad de Navarra (SUN) cohort. Am J Clin Nutr 82 (2005) 972-979
13. Ruidavets J.B., Bongard V., Simon C., Dallongeville J., Ducimetiere P., Arveiler D., et al. Independent contribution of dairy products and calcium intake to blood pressure variations at a population level. J Hypertens 24 (2006) 671-681
14. FitzGerald R.J., Murray B.A., and Walsh D.J. Hypotensive peptides from milk proteins. J Nutr 134 (2004) 980S-988S
15. Jauhiainen T., and Korpela R. Milk peptides and blood pressure. J Nutr 137 (2007) 825S-829S
16. Nakamura Y., Yamamoto N., Sakai K., Okubo A., Yamazaki S., and Takano T. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci 78 (1995) 777-783
17. Nakamura Y., Yamamoto N., Sakai K., and Takano T. Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. J Dairy Sci 78 (1995) 1253-1257
18. Sipola M., Finckenberg P., Santisteban J., Korpela R., Vapaatalo H., and Nurminen M.L. Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. J Physiol Pharmacol 52 (2001) 745-754
19. The Cochrane Collaboration. http://www.cochrane.org Last accessed March 20, 2008
20. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds J.M., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
21. Follmann D., Elliott P., Shu I., and Culter J. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol 45 (1992) 769-773
22. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
23. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
24. Aihara K., Kajimoto O., Hirata H., Takahashi R., and Nakamura Y. Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J Am Coll Nutr 24 (2005) 257-265
25. Jauhiainen T., Vapaatalo H., Poussa T., Kyronpalo S., Rasmussen M., and Korpela R. Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. Am J Hypertens 18 (2005) 1600-1605
26. Mizuno S., Matsuura K., Gotou T., Nishimura S., Kajimoto O., Yabune M., et al. Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension. Br J Nutr 94 (2005) 84-91
27. Sano J., Ohki K., Higuchi T., Aihara K., Mizuno S., Kajimoto O., et al. Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension. J Med Food 8 (2005) 423-430
28. Mizushima S., Ohshige K., Watanabe J., Kimura M., Kadowaki T., Nakamura Y., et al. Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. Am J Hypertens 17 (2004) 701-706
29. Tuomilehto J., Lindstrom J., Hyyrynen J., Korpela R., Karhunen M.L., Mikkola L., et al. Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension. J Hum Hypertens 18 (2004) 795-802
30. Seppo L., Jauhiainen T., Poussa T., and Korpela R. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am J Clin Nutr 77 (2003) 326-330
31. Seppo L., Kerojoki O., Suomalainen T., and Korpela R. The effect of a lactobacillus helveticus LBK-16 H fermented milk on hypertension-a pilot study on humans. Milchwissenschaft 57 (2002) 124-127
32. Hata Y., Yamamoto M., Ohni M., Nakajima K., Nakamura Y., and Takano T. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 64 (1996) 767-771
33. Dent M.P., O'Hagan S., Braun W.H., Schaetti P., Marburger A., and Vogel O. A 90-day subchronic toxicity study and reproductive toxicity studies on ACE-inhibiting lactotripeptide. Food Chem Toxicol 45 (2007) 1468-1477
34. Ondetti M.A., and Cushman D.W. Angiotensin-converting enzyme inhibitors: biochemical properties and biological actions. CRC Crit Rev Biochem 16 (1984) 381-411
35. Mizuno S., Nishimura S., Matsuura K., Gotou T., and Yamamoto N. Release of short and proline-rich antihypertensive peptides from casein hydrolysate with an Aspergillus oryzae protease. J Dairy Sci 87 (2004) 3183-3188
36. Masuda O., Nakamura Y., and Takano T. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr 126 (1996) 3063-3068
37. Foltz M., Meynen E.E., Bianco V., van Platerink C., Koning T.M., and Kloek J. Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation. J Nutr 137 (2007) 953-958
38. Cadee J.A., Chang C.Y., Chen C.W., Huang C.N., Chen S.L., and Wang C.K. Bovine casein hydrolysate (c12 Peptide) reduces blood pressure in prehypertensive subjects. Am J Hypertens 20 (2007) 1-5
39. Townsend R.R., McFadden C.B., Ford V., and Cadée J.A. A randomized, double-blind, placebo-controlled trial of casein protein hydrolysate (C12 peptide) in human essential hypertension. Am J Hypertens 17 11, pt 1 (2004) 1056-1058
40. Pins J.J., and Keenan J.M. Effects of whey peptides on cardiovascular disease risk factors. J Clin Hypertens 8 (2006) 775-782
41. Lee Y.M., Skurk T., Hennig M., and Hauner H. Effect of a milk drink supplemented with whey peptides on blood pressure in patients with milk hypertension. Eur J Nutr 46 (2007) 21-27
42. Inoue K., Shirai T., Ochiai H., Kasao M., Hayakawa K., Kimura M., et al. Blood-pressure-lowering effect of a novel fermented milk containing γ-aminobutyric acid (GABA) in mild hypertensives. Eur J Clin Nutr 57 (2003) 490-495
43. Qin L.Q., Xu J.Y., Wang P.Y., Kaneko T., Hoshi K., and Sato A. Milk concentration is a risk factor for prostate cancer: meta-analysis of case-control studies. Nutr Cancer 48 (2004) 22-27